ANIX TREND PREDICTIONA multi-year trend analysis to see if upcoming catalyst will push upward momentum past current resistance highs.
Key stats
Market capitalization
122.153MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.40USD
About Anixa Biosciences, Inc
ISIN
US03528H1095
Sector
Health Technology
Industry
Biotechnology
Website
anixa.com
CEO
Amit D. Kumar
Headquarters
San Jose
Employees
5
Founded
1982
Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that are focused on critical unmet needs in oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, Cancer Diagnostics, and Patent Licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
ANIX: Bouncing off 200MABounced off 200MA acting as resistance 4X in the last year.
Just did the same yesterday. Reversed on 2.81 resistance.
250RSI below 50 = bearish
200MA pointing south = bearish
If confirmed, should see some move South.
Target #1 = 1.51 $ support level
Target #2 = 0.66 $ support level
7 - $ANIX In love with this stockVery simple set up for direction confirmation. I have a large position in this stock for 2 weeks.
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0